These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2403033)
1. In vivo metabolism and UTP-depleting action of 2-deoxy-2-fluoro-D-galactose. Grün BR; Berger U; Oberdorfer F; Hull WE; Ostertag H; Keppler D Adv Enzyme Regul; 1990; 30():231-42. PubMed ID: 2403033 [TBL] [Abstract][Full Text] [Related]
2. Metabolism and actions of 2-deoxy-2-fluoro-D-galactose in vivo. Grün BR; Berger U; Oberdorfer F; Hull WE; Ostertag H; Friedrich E; Lehmann J; Keppler D Eur J Biochem; 1990 May; 190(1):11-9. PubMed ID: 2114284 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of protein N-glycosylation by 2-deoxy-2-fluoro-D-galactose. Gross V; Hull WE; Berger U; Andus T; Kreisel W; Gerok W; Keppler D Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):821-6. PubMed ID: 1497619 [TBL] [Abstract][Full Text] [Related]
4. Accumulation of 2-deoxy-2-[18F]fluoro-D-galactose in the liver by phosphate and uridylate trapping. Ishiwata K; Ido T; Imahori Y; Yamaguchi K; Fukuda H; Tada M; Matsuzawa T Int J Rad Appl Instrum B; 1988; 15(3):271-6. PubMed ID: 3260229 [TBL] [Abstract][Full Text] [Related]
5. Metabolic pathway of 2-deoxy-2-[18F]fluoro-D-talose in mice: trapping in tissue after phosphorylation by galactokinase. Haradahira T; Maeda M; Kato A; Kanazawa Y; Yamada M; Torii Y; Ichiya Y; Masuda K Nucl Med Biol; 1994 Feb; 21(2):269-76. PubMed ID: 9234293 [TBL] [Abstract][Full Text] [Related]
6. Uridylate trapping, induction of UTP deficiency, and stimulation of pyrimidine synthesis de novo by D-galactosone. Keppler DO; Schulz-Holstege C; Fauler J; Reiffen KA; Schneider F Biochem J; 1982 Jul; 206(1):139-46. PubMed ID: 7126188 [TBL] [Abstract][Full Text] [Related]
7. 2-Deoxy-2-[18F]fluoro-D-galactose as an in vivo tracer for imaging galactose metabolism in tumors with positron emission tomography. Ishiwata K; Yamaguchi K; Kameyama M; Fukuda H; Tada M; Matsuzawa T; Muraishi K; Itoh J; Kawashima K; Takahashi T Int J Rad Appl Instrum B; 1989; 16(3):247-54. PubMed ID: 2785512 [TBL] [Abstract][Full Text] [Related]
8. In vivo assessment of 6-deoxy-6-[18F]fluoro-D-galactose as a PET tracer for studying galactose metabolism. Ishiwata K; Tomura M; Ido T; Iwata R; Itoh J; Kameyama M Int J Rad Appl Instrum B; 1989; 16(8):775-81. PubMed ID: 2621112 [TBL] [Abstract][Full Text] [Related]
9. 2-Deoxy-2-[18F]fluoro-D-galactose: a new tracer for the measurement of galactose metabolism in the liver by positron emission tomography. Fukuda H; Matsuzawa T; Tada M; Takahashi T; Ishiwata K; Yamada K; Abe Y; Yoshioka S; Sato T; Ido T Eur J Nucl Med; 1986; 11(11):444-8. PubMed ID: 3486765 [TBL] [Abstract][Full Text] [Related]
10. Enzymatic synthesis of UDP-(3-deoxy-3-fluoro)-D-galactose and UDP-(2-deoxy-2-fluoro)-D-galactose and substrate activity with UDP-galactopyranose mutase. Barlow JN; Blanchard JS Carbohydr Res; 2000 Oct; 328(4):473-80. PubMed ID: 11093703 [TBL] [Abstract][Full Text] [Related]
11. Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats. Lattke H; Koch HK; Lesch R; Keppler DO Virchows Arch B Cell Pathol Incl Mol Pathol; 1979 Jun; 30(3):297-312. PubMed ID: 43010 [TBL] [Abstract][Full Text] [Related]
12. Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT. Sørensen M; Mikkelsen KS; Frisch K; Bass L; Bibby BM; Keiding S J Nucl Med; 2011 Oct; 52(10):1566-72. PubMed ID: 21875925 [TBL] [Abstract][Full Text] [Related]
13. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine. Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194 [TBL] [Abstract][Full Text] [Related]
14. 2-Deoxy-D-galactose metabolism in ascites hepatoma cells results in phosphate trapping and glycolysis inhibition. Smith DF; Keppler DO Eur J Biochem; 1977 Feb; 73(1):83-92. PubMed ID: 190012 [TBL] [Abstract][Full Text] [Related]
15. Imaging of rats with mammary cancer with two 2-deoxy-2-[18F]fluoro-D-hexoses. Paul R; Aho K; Bergman J; Haaparanta M; Kulmala J; Reissell A; Solin O Int J Rad Appl Instrum B; 1989; 16(5):449-53. PubMed ID: 2509402 [TBL] [Abstract][Full Text] [Related]
16. Cerebral metabolism of fluorodeoxyglucose measured with 19F NMR spectroscopy. Pouremad R; Wyrwicz AM NMR Biomed; 1991 Aug; 4(4):161-6. PubMed ID: 1931555 [TBL] [Abstract][Full Text] [Related]
17. Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography. Sørensen M; Munk OL; Mortensen FV; Olsen AK; Bender D; Bass L; Keiding S Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G27-G36. PubMed ID: 18483186 [TBL] [Abstract][Full Text] [Related]
19. 3-Fluoro-3-deoxy-D-galactose: a new probe for studies on sugar cataract. Secchi EF; Lizak MJ; Sato S; Kador PF Curr Eye Res; 1999 Apr; 18(4):277-82. PubMed ID: 10372987 [TBL] [Abstract][Full Text] [Related]
20. The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease. Mikkelsen KS; Sørensen M; Frisch K; Villadsen GE; Bibby BM; Keiding S J Nucl Med; 2014 Apr; 55(4):590-4. PubMed ID: 24591487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]